Abstract 351: Size Matters: Saving the Penumbra
Circulation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/Suppl_1″>Volume 13, Issue Suppl_1</a>, Page A351-A351, May 1, 2020. Source link
Read moreCirculation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/Suppl_1″>Volume 13, Issue Suppl_1</a>, Page A351-A351, May 1, 2020. Source link
Read moreBackground: The economic burden of stroke is high and expected to increase with the growing stroke incidence among younger adults
Read moreIntroduction: Heart Failure is one of the leading causes of readmission in the United States. Heart Failure with preserved Ejection
Read moreBackground: The goals of TAVR and transcatheter mitral valve repair (TMVr) are to prolong survival, reduce heart failure (HF) hospitalizations,
Read moreBackground: Readmissions following acute myocardial infarction (MI) are associated with increased cost, healthcare utilization, and morbidity. The purpose of this
Read moreIn the U.S., diabetes is the 7th leading cause of death and 65% of these deaths are attributable to cardiovascular
Read moreBackground: Comorbid sleep apnea in cardiovascular disease is a predictor of adverse cardiovascular outcomes. It is unknown whether comorbid sleep
Read moreHeart failure decompensations accounts for over one million hospitalizations annually and are the most common cause of US hospital admission
Read moreBackground: Socioeconomic markers such as income level are associated with cardiovascular disease (CVD). However, the associations between income and utilization
Read moreBackground: Rate control medications (RCM) for atrial fibrillation (AF) usually prescribed are diltiazem (DTZ) and beta blockers. Patients entering the
Read more